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Introduction: The deterioration of cognition is highly predominant in older adults. 
Objective: The aim of this study was to analyze the effects of a walking program on the cognition and 
blood concentration of lipids in women over 60 years of age who were being treated with lovastatin.
Materials and methods: Participants were distributed in two groups: An exercise group (EG, n=45) 
with aerobic training and an inactive sedentary group (SG, n=22). The cognitive state of the subjects 
was assessed through the Spanish Mini-Cog Test version of the MMSE; lipoproteins were quantified 
using a lipid profile test, and the cardiorespiratory fitness was measured using the six-minute walking 
test (6MWT).
Results: EG showed a significant increase (p<0.05) in cardiorespiratory fitness and in HDL-C 
concentrations. Furthermore, the results from the cognition tests showed a large effect size in spatial 
orientation and in and calculation. The decrease in LDL-C was not significant (p>0.05).
Conclusion: A controlled and progressive walking program for older women treated with Lovastatin 
may induce a boost of brain activity linked to HDL-C, which could delay cognitive impairment.
Key words: Exercise; cognition; dyslipidemia; hydroxymethylglutaryl-CoA reductase inhibitors; mental 
health; aging.
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Efectos del ejercicio físico sobre la cognición en mujeres mayores tratadas con lovastatina
Introducción. El deterioro cognitivo tiene una gran incidencia en el adulto mayor.
Objetivo. El principal objetivo de este estudio fue analizar los efectos sobre la cognición y la 
concentración de lípidos de un programa de caminatas en mujeres mayores de 60 años tratadas con 
lovastatina.
Materiales y métodos. Las participantes se distribuyeron en dos grupos: uno con ejercicio (EG, n=45) 
sometido a entrenamiento aeróbico y otro inactivo o sedentario (SG, n=22). El estado cognitivo se 
evaluó mediante la versión en español del Mini-Mental Test. Los niveles de lipoproteínas se midieron 
con una prueba de perfil lipídico y la aptitud cardiorrespiratoria se valoró con la prueba de caminata de 
6 minutos (Six-Minute Walking Test, 6MWT).
Resultados. El grupo con ejercicio mostró una mejora significativa (p<0,05) de la aptitud 
cardiorrespiratoria y de las concentraciones de colesterol HDL. Además, en la prueba de cognición 
se observó un efecto de gran tamaño en la orientación espacial, en la atención y en el cálculo. La 
reducción del colesterol LDL no fue significativa. 
Conclusión. Un programa de entrenamiento progresivo y supervisado para mujeres mayores tratadas 
con lovastatina, podría mejorar la actividad cerebral relacionada con el colesterol HDL, lo cual podría 
retrasar el deterioro cognitivo.
Palabras clave: ejercicio; cognición; dislipidemias; inhibidores de hidroximetilglutaril-CoA reductasa; 
salud mental; envejecimiento.
doi: https://doi.org/10.7705/biomedica.v38i4.4262
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A sedentary lifestyle is a determining factor for the 
appearance of dyslipidemia, which is associated 
with the development of atherosclerotic diseases 
(1,2). Recent studies have reported on the effects 
of supervised exercise on the improvement of 
blood pressure (3,4), the decrease in LDL-C (5,6), 
and the increase in HDL-C (7,8). The efficiency 
of cardiorespiratory fitness training has also been 
demonstrated, as it drives beneficial changes in the 
levels of serum lipoproteins in women and obese 
men (9).
Several studies have reported the beneficial effects 
of regular and systematic exercise to maintain normal 
lipid levels, to increase HDL-C concentrations, (10) 
and to prevent atheroma plaque formation reducing 
LDL-C (11). In this sense, it has been previously 
shown that the length and type the training program 
seem to be essential elements of the effect on 
plasma lipoproteins (12-14). However, despite all 
the physiological and enzymatic changes caused 
by training, the mechanisms by which exercise 
reduces atherogenic risk are still unknown (15). 
Apparently, its beneficial effects on the reduction 
of high plasma cholesterol (16,17) depend upon 
the characteristics of exercise training (18), which 
demands more research on the effects of the 
type and intensity of exercise for the reduction of 
blood lipids (Wells JR. Medium-intensity rhythmic 
exercise and high-intensity resistance exercise 
reduces fasting plasma cholesterol/HDL ratio. 37th 
Congress of IUPS (Birmingham, UK) (2013), Proc. 
37th IUPS, PCC236).
Statin treatments have also been shown to 
have a beneficial effect on the reduction of total 
cholesterol and LDL-C and on the prevention of 
arterial diseases and ischemic cerebrovascular 
accidents (19), thus becoming a cornerstone for 
the treatment of dyslipidemia (20,21). While some 
researchers have found mild adverse effects on 
cognition (22), others studies have reported a 
beneficial effect of statins on cognitive function (23-
25), and others could not prove its beneficial effect 
on cognitive function in elders (26,27). Therefore, 
firm conclusions regarding whether statin use 
affects cognition function and dementia remain 
elusive. 
Concern exists that statins may be a causative 
factor for cognitive problems; however, this adverse 
effect appears to be rare and likely represents 
a yet-to-be-defined vulnerability in susceptible 
individuals (28). 
In this regard, it seems clear that there is a 
relationship between cognitive disturbance and 
increased concentrations of serum low-density 
lipoproteins (29-31); also, low levels of HDL-C 
seem to be linked to poor cognitive function (32,33).
It has been shown that exercise could reduce the 
risk of cognitive decline in older people (34,35), and 
although a systematic review concluded that there is 
no solid evidence that exercise improves cognition 
in older adults, some studies have also reported 
the need for further research with exercise to 
confirm its effect on cognition (36,37). Accordingly, 
a preventive effect on cognitive decline has been 
attributed to exercise (38), since it improves frontal 
lobe activity (39) and brain plasticity (40) favoring 
cognitive performance and executive function 
in adults (41) . Moreover, it has been shown that 
exercise activates numerous molecular and cellular 
signals involved in multiple processes of the central 
nervous system (42) with large benefits for mental 
health and against depressive states (43), which 
also calls for further research to confirm its effects 
on cognition (37).
Likewise, low concentrations of HDL-C combined 
with inflammatory states are considered as 
predicting factors of a poor general cognitive 
performance and a decrease in information 
processing speed (44). On the other hand, an 
increase of HDL-C concentrations has been 
observed as a response to an exercise program 
of aerobic resistance (45) along with an adequate 
diet (46), where low concentrations of HDL-C were 
associated with memory decline, which is the 
first stage of mild cognitive decline (47), coronary 
diseases, and long-term depressive symptoms 
(48).
A recent study reported that the combination of 
statins and exercise appears to be associated with 
significant improvement in the cognition of patients 
with coronary artery disease and mild pre-existing 
cognitive dysfunction (49).
The associations between plasma lipids and 
cognition and the underlying mechanism, as well 
as the relationship between statins and cognitive 
function, are complex and currently not fully 
understood. 
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Therefore, more research will provide insights into 
the causes and interdependencies of cognitive 
impairment and dementia (28).
The purpose of this study was to analyze the 
effects of progressive walk-based cardiorespiratory 
exercise on cognitive function and the serum levels 
of HDL-C and LDL-C, in older women on antilipemic 
treatment with lovastatin. 
Materials and methods
We conducted a quasi-experimental, non-probabi- 
listic prospective study in a two-group pre-test-
post-test design. The sample (n=67) was com- 
posed of older adult women who were patients of 
the health center “La Estrella” at the commune of 
Pudahuel (Chile). These women were diagnosed 
with dyslipidemia and were following a lovastatin 
treatment (20 mg/day). The sample size was 
calculated with a 5 % alpha and a 95% confidence 
level. The women were randomly assigned to the 
exercise group (EG, n=45) with (X±SD) 67.8 ± 5.0 
years of age and the sedentary group (SG, n=22) 
with (X±SD) 71.9 ± 5.4 years of age. The women 
in both groups showed a level of education that 
allowed them to read and write without help.
The biochemical profile to determine LDL-C and 
HDL-C concentrations was performed from 10 ml 
blood samples extracted from each subject after 
12 hours fasting. Cognitive decline was assessed 
through the Mini-Cog Test Spanish version (50) 
based on the Mini-Mental State Examination 
(MMSE) (51), with a total score of three points. The 
cut-off for cognitive decline is 24/25 for the sum of 
the domains of temporal and spatial orientation, 
fixation-immediate recall, attention-calculation, 
delayed recall, and language (52).
The six-minute walking test (6MWT) was used 
to assess cardiorespiratory performance (VO2 
max). It showed good validity and reliability at 
estimating maximum aerobic capacity in subjects 
with different pathologies (53-56) and accuracy at 
predicting maximum cardiorespiratory function in 
the healthy population (57) and assessing health-
related physical fitness (58). It was applied before 
and after the intervention in homogenous groups of 
five people at a 400 m flat track.
The following inclusion criteria were considered: 
(i) Women between 60 and 80 years of age 
participating in the cardiovascular program of the 
health center “La Estrella” with their clinical tests 
updated; (ii) medical clearance compatible with 
Mesocycle 1 Mesocycle 2
Weeks 1 2 3 4 5 6 7 8
%VO2max. 45 45 50 45 50 45 50 60
Km/hour 2.7 2.7 3.3 2.7 3.3 2.7 3.3 4.3
Mesocycle 3 Mesocycle 4
Weeks 9 10 11 12 13 14 15 16
%VO2max. 45 50 60 50 60 45 50 60
Km/hour 2.7 3.3 4.3 3.3 4.3 2.7 3.3 4.3
the requirements of the cardiovascular training; (iii) 
patients diagnosed with dyslipidemia and treated 
with lovastatin (20 mg/day); (iv) pharmacological 
treatment length between 13 and 15 months; 
(v) MMSE score ≤24 points, i.e., “mild cognitive 
decline”; (vi) patients with reading and writing skills, 
and (vii) signed informed consent approved by the 
board of the health center and the Universidad 
Metropolitana de Ciencias de la Educación in 
Santiago de Chile. 
The exclusion criteria considered were: (i) 
Depressive patients with medication; (ii) patients 
with pathologic conditions incompatible with 
exercise; (iii) patients without the basic educational 
level, and (iv) patients with severe pathologies 
during the study.
The cardiorespiratory training consisted of a 
progressive walk on a horizontal plane, throughout 
a period of 16 consecutive weeks distributed in 
three sessions per week one hour per session, with 
two active rest periods of 5 minutes.
The progressive walk training program included 
these phases: A 10-minute warm-up for joint 
mobility and general and specific flexibility. The 
following chart shows the main characteristics of 
the program:
The cool-down routine was done for 10 minutes 
including general and specific flexibility.
Data analysis
The statistical processing of data was performed 
using the IBM SPSS 20™ software. The normality 
was tested with the Shapiro-Wilk test and the 
homoscedasticity with the Levene test. The two 
groups were compared using the Student´s 
t-test if they met the conditions of normality and 
equal variances, and the Mann-Whitney´s U-test 
was used otherwise. The Student´s t-test or the 
Wilcoxon test were used to compare paired data 
according to their normality. The effect size was 
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Exercise group (n=45)
Pre
(Mean ± SD)
Post
(Mean ± SD)
Change
(Mean ± SD)
p value*
Effect
size§
Magnitude
MMSE (score) 23.9 ± 2.1 27 ± 1.9 3.2 ± 2.3 0.000 1.67 Large
HDL-C (mg/dl) 49.8 ± 7.5 55.2 ± 10.1 5.4 ± 6.1 0.000 0.53 Medium
LDL-C (mg/dl) 130 ± 29.5 127 ± 28.8 -3.3 ± 33.6 0.509 0.11 Small
6MWT (meters) 547 ± 42.3 572 ± 43.6 25.1 ± 27.9 0.000 0.58 Medium
Sedentary group (n=22)
Pre
(Mean ± SD)
Post
(Mean ± SD)
Change
(Mean ± SD)
p value*
Effect
size§
Magnitude
MMSE (score) 23.5 ± 1.7 23.7±2.1 0.3 ± 1.8 0.564 0.13 Small
HDL-C (mg/dl) 52.4 ± 11.2 47.5 ± 12.1 -4.9 ± 3.6 0.000 0.4 Medium
LDL-C (mg/dl) 140 ± 25.7 135 ± 26 -5 ± 15.2 0.137 0.2 Small
6MWT (meters) 406 ± 62.9 401 ± 77.4 -5 ± 35.4 0.518 0.06 Small
MMSE: Mini-Mental State Examination; HDL-C: HDL-Cholesterol; LDL-C: LDL-Cholesterol; 6MWT: The six-minutes walking test
*: Student’s t test or Wilcoxon Significant: p<0.05 
§: Effect size (Cohen 1988)
calculated according to the Cohen´s equation (59). 
Regression and correlation among the variables of 
interest were calculated based on the regression 
curve and the correlation coefficient, respectively.
Ethical considerations
The project was approved by the Ethical Committee 
of the Universidad Pablo de Olavide in Seville 
and all the procedures met the indications of the 
Declaration of Helsinki approved by the World 
Medical Association (60).
Results
Table 1 shows the mean values and standard 
deviations obtained before and after the 
intervention, as well as the differences between 
the pre-tests and post-tests in both groups. It 
also shows the statistical significance values of 
the intragroup comparisons (paired data) for the 
means between pre- and post-tests and the effect 
size of such intervention. SG showed a slight non-
significant decrease (p=0.518) in the distance 
walked at the end of the experiment with the 
6MWT; however, EG showed a remarkable and 
statistically significant increase (p<0.05) at the end 
of the intervention. It also presents the changes 
produced in cognition in both groups, showing a 
significant increase (p<0.05) and a large effect size 
in the MMSE scores in EG, whereas SG did not 
show significant changes (p=0.564) between pre-
test and post-test. With respect to HDL-C levels, 
there was a statistically significant decrease in SG 
(p<0.05), while EG showed significant increases in 
HDL-C plasma concentration (p<0.05). Finally, this 
table also shows the results obtained from LDL-C 
levels, with non-significant decreases and a small 
effect size in both groups.
Table 2 shows the intragroup differences of the 
cognitive dimensions assessed by the MMSE, with 
a large effect size (p<0.05) in spatial orientation, 
attention, and calculation and a moderate effect in 
temporal orientation, fixation, recall, and language in 
EG. In contrast, SG showed no significant differences 
in the measurements analyzed.
Figure 1 shows the percentages of change between 
pre-test and post-test comparing such changes 
between groups. Except for LDL-C concentrations, 
there were statistically significant differences 
(p<0.001) in the rest of the variables between SG 
and EG. 
Table 1. Intragroup differences of the variables studied
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Exercise group (n=45)
Pre
(Mean ± SD)
Post
(Mean ± SD)
Change
(Mean ± SD)
p value*
Effect
size§
Magnitude
Temporal 
Orientation 
4.49 ± 0.55 4.76 ± 0.43 0.27 ± 0.45 0.001 0.61 Medium
Spatial 
Orientation 
4.49 ± 0.66 4.82 ± 0.39 0.33 ± 0.64 0.002 0.86 Large
Fixation 2.67 ± 0.52 2.89 ± 0.32 0.22 ± 0.52 0.008 0.70 Medium
Attention and 
Calculation
2.42 ± 1.22 3.69 ± 1.36 1.27 ± 1.36 0.000 0.93 Large
Recall 2.42 ± 0.62 2.69 ± 0.47 0.27 ± 0.62 0.008 0.57 Medium
Language 7.38 ± 1.27 8.13 ± 0.99 0.76 ± 1.32 0.001 0.76 Medium
MMSE 23.9 ± 2.1 27 ± 1.9 3.2 ± 2.3 0.000 1.68 Large
Sedentary group (n=22)
Pre
(Mean ± SD)
Post
(Mean ± SD)
Change
(Mean ± SD)
p value*
Effect
size§
Magnitude
Temporal 
orientation 
4.55 ± 0.67 4.73 ± 0.55 0.18 ± 0.80 0.271 0.33 Small
Spatial 
orientation 
4.91 ± 0.29 4.91 ± 0.29 0.00 ± 0.44 1.000 0.00
Fixation 2.91 ± 0.29 2.95 ± 0.21 0.05 ± 0.38 0.564 0.21 Small
Attention and 
calculation
1.36 ± 1.40 1.09 ± 1.41 -0.27 ± 1.49 0.382 -0.19 Small
Recall 2.64 ± 0.58 2.64 ± 0.58 0.00 ± 0.76 1.000 0.00
Language 7.09 ± 1.02 7.41 ± 1.26 0.32 ± 0.89 0.100 0.25 Small
MMSE 23.5 ± 1.74 23.7 ± 2.05 0.27 ± 1.78 0.564 0.13 Small
1MMSE: Mini-Mental State Examination
*: Student’s t-test or Wilcoxon Significant: p<0.05 
§: Effect size (Cohen 1988)
Table 2. Intragroup differences in the cognitive dimensions of the MMSE1
Figure 1. Intergroup comparisons and percent change
* p<0.001 Mann-Whitney U test
MMSE HDL-C LDL-C 6MWT-12
-7
-2
3
8
13.9*
1.2
-9.3
Exercise group
Sedentary group
-3.6
-2.6
4.7*
-1.2
10.8*
13
18
Figure 2 shows the association of the results 
obtained after the intervention between the 
variables “fitness expressed in distance walked in 6 
minutes” and the MMSE scores in EG and SG.SG 
showed a negative correlation (r=-0.08; R2=0.007) 
with a wide scatter of the data with respect to the 
regression line. However, EG at the end of the 
study showed a positive although weak correlation 
(r=0.22; R2=0.049). In both cases, the results were 
not significant.
Figure 3 shows the results obtained in the linear 
regression analysis between the final results of the 
6MWT and the HDL-C (mg/dl). 
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Figure 4. Post-intervention linear regression analysis between 
6MWT and HDL-C. No significant correlation in the sedentary 
group (p>0.05) and significant correlation in the exercise group 
(p<0.05)
Figure 2. Post-intervention linear regression analysis between 
6MWT and MMSE. No significant correlation was found in any 
of the groups (p>0.05)
Figure 3. Post-intervention linear regression analysis between 
6MWT and HDL-C. We found no significant correlation in the 
exercise group (p>0.05) and a significant correlation in the 
sedentary group (p<0.05)
The association between these two variables 
at the end of the study in SG showed statistical 
significance (r=0.61; R2=0.37). However, the 
results of EG showed a weak (r=0.09; R2=0.009), 
non-significant correlation.
Figure 4 shows that the scatter between 
cardiorespiratory performance (6MWT) and LDL-C 
concentrations after the intervention presented a 
positive, weak correlation (r=0.21; R2=0.046) in 
SG that was not significant (p>0.05); in turn, EG 
showed a negative correlation coefficient (r=-0.34; 
R2=0.12) that was statistically significant (p<0.05).
Discussion
The aim of this study was to analyze the effects 
of systematized exercise on cognitive decline 
and plasma lipoproteins concentrations. At the 
beginning of the study, the presence of mild 
cognitive impairment was verified in the two groups 
studied; however, at the end of the intervention, EG 
showed a normal cognitive state with a significant 
increase (p<0.05) in the comparison between 
the MMSE pre- and post-tests. SG did not show 
significant changes in cognition (table 1). Thus, 
the differences between groups in the percentages 
of change were statistically significant for this 
variable (p<0.001) (figure 1). Therefore, the group 
that combined a training program with a lovastatin 
treatment (EG) obtained a beneficial effect on 
mild cognitive decline with a large effect size in 
the increase of MMSE scores. These results are 
consistent with the study by Sparks, et al. (61), 
who reported that MMSE performance decreased 
significantly with time in those subjects that did not 
take any lipid reducing drug. They also observed a 
significant correlation between MMSE and HDL in 
subjects treated with statins, although the existing 
evidence to prove the role of physical activity in the 
improvement of cognition in older adults is limited 
(36).
The absence of changes in MMSE in SG could be 
associated with mild cognitive decline, considered 
as a precursor of cognitive decline, which in turn 
compromises one or more higher mental functions 
(62,63). In this sense, it has been reported that 
some statins have differentiated effects on brain 
function: they can deteriorate cognition or either 
have a neutral or beneficial effect. However, some 
findings reported in the literature contrast with 
the effects related to statins. A slight decrease 
in cognitive decline has been observed in older 
people (64) while another study reports on the 
differentiated effects on brain function (65), which 
suggest that further research is required to confirm 
or refute the possible effects of statins on cognitive 
function.
Delving into this argument, in this study no 
significant differences were found (p>0.05) for 
SG, neither in the MMSE scores nor in any of its 
measurements, whereas EG showed statistically 
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significant differences (p<0.05) in six dimensions 
of the MMSE (table 2), with a large effect size in 
spatial orientation and attention and in calculation, 
and a moderate effect size for temporal orientation, 
fixation, recall, and language. Thereby, the 
lovastatin treatment combined with an improved 
level of cardiorespiratory fitness seems to induce 
a protective effect on cognition in older women, 
which is in line with other studies reporting that 
physical activities like walking may help improve 
cognitive function in patients with vascular cognitive 
impairment of subcortical origin (66), or with 
studies which state that greater cardiorespiratory 
fitness is strongly related to global cognitive 
function, attention/executive function, information 
processing speed, problem solving, and inhibition 
(67,68). It has also been demonstrated that 
exercise with moderate intensity improves cognitive 
function by influencing certain regions of the brain, 
like the prefrontal area and the hippocampus, 
increasing memory and executive function mainly 
through aerobic or cardiorespiratory exercise (69). 
In combination with the treatment with statins, 
exercise could have beneficial effects on blood lipid 
levels and, thus, on brain functions (70), although 
in this study no significant relationship was found 
between the total distance walked and the general 
MMSE score (figure 2). Even though physical 
activity has been associated with neurological 
improvements, other mechanisms could also be 
involved, like neurogenesis, synaptogenesis or 
changes in the levels of inflammatory markers (68), 
variables that were not monitored in this study.
Table 1 shows a significant decrease in HDL-C 
blood levels (p<0.05) in SG. This suggests that 
the treatment with lovastatin on its own did not 
increase HDL-C concentration, which is consistent 
with other studies reporting that statins do not alter 
the relationship between HDL-C and the level of 
cardiovascular risk (71). On the other hand, EG 
showed the opposite inclination, with a significant 
increase (p<0.05) in the levels of HDL-C and a 
medium effect size (table 1), which is in line with 
other studies reporting that statins could reduce the 
risk of cerebrovascular accidents (72), although in 
this case, the differential element was the exercise 
program carried out by the group.
Likewise, a positive relationship was found between 
cardiorespiratory fitness (6MWT) and HDL-C 
concentrations in both groups (figure 3). However, 
this correlation was statistically significant only 
in SG (p<0.05), i.e., those subjects with better 
cardiorespiratory fitness showed greater levels 
of HDL-C. Although it has been reported that 
cardiorespiratory exercise increases HDL-C 
concentrations (73), in the present study there was a 
weak, non-significant correlation (p>0.05) between 
physical performance and HDL-C concentrations 
in the group that carried out the exercise program 
(figure 3). Similar results have been found in a 
study reporting that a form of statin (simvastatin) 
attenuates the increase of cardiorespiratory fitness 
and the mitochondrial content in muscles when it is 
combined with exercise in patients under the risk of 
metabolic syndrome (74). Although the data of the 
correlations appear to be in contradiction, when the 
percentages of change between groups (figure 1) 
for the concentrations of HDL-C were compared, 
a significant difference (p<0.001) was observed 
between SG and EG, with a decrease of 9.3% and 
an increase of 10.8%, respectively.
With respect to the results obtained for LDL-C 
concentrations, table 1 shows a non-significant 
decrease (p>0.05) in SG with a small effect size. 
These results are in contrast with studies in which 
the use of statins produced significant reductions 
of LDL-C without severe side effects (75). 
Likewise, the differences in EG were not significant 
(p=0.509), even though it has been reported in 
patients with coronary disease that statin treatment 
combined with exercise resulted in the significant 
improvement of the arterial wall stiffness (76). 
After comparing the changes between groups, no 
significant differences were found in this variable 
(figure 1). In this sense, EG showed a statistically 
significant negative correlation (p<0.05) between 
cardiorespiratory fitness and LDL-C, whereas 
the correlation between the same variables was 
positive for SG, although not significant (p>0.05) 
(figure 4). These opposite trends between groups 
could be explained by the effect attributed to the 
lovastatin treatment on LDL-C, which may be due 
to the low dosage. In seventy-five studies related 
to coronary disease and the reducing effect of 
statins on cholesterol and its differentiated effects, 
it has been reported that a daily dose of 40-80 mg 
of lovastatin could decrease LDL-C by 30-40%, 
and 10-20 mg of lovastatin could decrease LDL-C 
by 20-30% (77), or it could be due to the effect 
attributed to the exercise program in EG (78).
Finally, regarding cardiorespiratory fitness, a non-
significant decrease (p=0.518) was observed 
for SG in the distance walked (6MWT) after the 
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intervention, whereas the distance walked by EG 
increased significantly (p<0.05), with a moderate 
effect size (table 1). On the other hand, the differe-
nces in the percentages of change in 6MWT 
between groups (figure 1) were significant (p<0.05). 
This could be related to a reduction in the risk of 
dementia due to the direct relationship between 
brain functionality and integrity (79).
The results obtained in the present study support 
the beneficial effects of a monitored walk exercise 
of moderate intensity performed regularly and 
systematically and combined with the intake of 20 
mg of lovastatin on a better prognosis of cognitive 
performance associated with the increase in the 
concentrations of high-density lipoproteins in the 
sample studied.
Furthermore, these findings reveal that sedentary 
older women, even with the intake of lovastatin, are 
more vulnerable to atherogenic damage due to the 
low concentrations of HDL-C and to the exiguous 
decreases of LDL-C. Likewise, a positive correlation 
has been observed between the improvements in 
cardiorespiratory fitness and the levels of HDL-C in 
the population studied. 
Regarding limitations, only participants from a 
single health center were selected, which lowers the 
generalizability of these findings. This correlation 
was more evident in the sedentary group than in 
the active group, which shows that it is necessary 
to modify the present research design to eluci-
date the selective effects of lovastatin and aerobic 
exercise in older dyslipidemic adults. In addition, an 
important number of participants from the seden-
tary group dropped out, probably because in this 
group the monitoring of the exercise program was 
not carried out.
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